GNH USA

Europe — EMA

Metopirone Esteve Pharmaceuticals (Metyrapone)

GNH USA supplies Metopirone Esteve Pharmaceuticals (Metyrapone), a 11‑beta‑hydroxylase inhibitor for adrenal insufficiency testing and Cushing's syndrome

Metyrapone

Request sourcing

1
Pack/s

What is Metyrapone?

Metyrapone, the active ingredient in Metopirone Esteve Pharmaceuticals, is a 11‑beta‑hydroxylase inhibitor presented as an oral dosage form for oral use. It is employed in diagnostic testing of adrenal insufficiency and in the management of Cushing's syndrome.

GNH USA supplies Metopirone Esteve Pharmaceuticals as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, with established logistics for regulated markets across Europe, Asia and the Americas. Our quality‑assured distribution network ensures product integrity and timely delivery to healthcare providers.

What is Metyrapone used for?

Metyrapone acts on adrenal steroidogenesis, affecting cortisol production.

Diagnostic testing for adrenal insufficiency: helps assess adrenal cortisol reserve. Treatment of Cushing's syndrome: reduces excess cortisol synthesis. Evaluation of adrenal steroidogenesis disorders: assists in characterizing enzyme defects. Preoperative assessment of adrenal function: informs surgical planning for adrenal tumors.

What are the side effects of Metyrapone?

Metyrapone may cause a range of adverse reactions, varying from mild to serious.

Common Side Effects: - Nausea or vomiting - Dizziness or headache - Fatigue or weakness - Abdominal discomfort

Serious or Rare Side Effects: - Adrenal crisis due to abrupt cortisol withdrawal - Severe hypertension or hypertensive emergency - Significant hypokalemia or electrolyte disturbance

What precautions apply to Metyrapone?

When using Metyrapone, clinicians should observe several safety considerations.

Monitor cortisol levels: assess for inadequate suppression. Check electrolyte balance: watch for hypokalemia. Use caution in patients with hypertension: may exacerbate blood pressure. Avoid abrupt discontinuation: risk of adrenal crisis. Store at room temperature: keep in original container, protect from moisture.

What does Metyrapone interact with?

Metyrapone can interact with other medicines, influencing its efficacy or safety.

Major Interactions (Avoid): - Ketoconazole: additive inhibition of steroidogenesis. - Rifampin: induces hepatic enzymes, reducing metyrapone exposure. - Phenytoin or other enzyme‑inducing anticonvulsants.

Moderate Interactions (Monitor Closely): - Oral contraceptives: may reduce hormonal efficacy. - Antihypertensive agents: blood pressure changes may require adjustment. - Non‑steroidal anti‑inflammatory drugs (NSAIDs): potential for renal electrolyte effects.

Frequently asked questions

What is Metopirone used for?+
Metopirone, containing the active ingredient metyrapone, is used primarily for diagnostic testing of adrenal insufficiency and for the medical management of Cushing's syndrome, where it helps lower excess cortisol production.
How does Metyrapone work?+
Metyrapone inhibits the adrenal enzyme 11‑beta‑hydroxylase, blocking the final step of cortisol synthesis. This reduces cortisol output and leads to accumulation of precursor steroids that can be measured for diagnostic purposes or used therapeutically to control hypercortisolism.
What is the usual dose of Metopirone?+
The dosage of Metopirone is individualized and must be prescribed by a qualified healthcare professional. The prescriber determines the amount, frequency, and duration based on the specific indication and patient response.
Is Metopirone safe in pregnancy or breastfeeding?+
Safety data for metyrapone during pregnancy and lactation are limited. It should only be used when the potential benefit to the mother outweighs any possible risk to the fetus or infant, and under close medical supervision.
How do I order Metopirone from GNH USA?+
To order Metopirone, submit an enquiry on the product page at gnh-usa.com, specifying the required quantity. GNH USA works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.
How does Metopirone compare with the main alternative drug?+
The most common alternative for cortisol suppression is ketoconazole, another steroidogenesis inhibitor. Compared with ketoconazole, metyrapone has a more selective action on 11‑beta‑hydroxylase and may be preferred when liver toxicity is a concern, although individual response varies.
How should Metopirone be stored and handled?+
Metopirone should be stored at room temperature, below 25 °C, in its original packaging. Keep the product away from moisture and direct sunlight to maintain stability and potency.
How is Metopirone administered?+
Metopirone is administered orally, typically as tablets or capsules, and should be taken according to the prescribing clinician’s instructions, usually with or without food as directed.
What are the most serious risks to watch for while taking Metopirone?+
Serious risks include adrenal crisis from sudden cortisol withdrawal, severe hypertension, and significant electrolyte disturbances such as hypokalemia. Patients should be monitored closely for these events, especially during dose changes.
Who should not use Metopirone?+
Metopirone is contraindicated in individuals with known hypersensitivity to metyrapone, severe uncontrolled hypertension, or significant liver impairment. Caution is also advised for patients with pre‑existing electrolyte abnormalities.
Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.
Send a sourcing enquiry for this product →

Product details

Drug
Metyrapone
Route
Oral Use
Manufacturer
Esteve Pharmaceuticals, S.A.
Origin
EU

Related products

Cormeto

Cormeto

Metyrapone

Esteve Pharmaceuticals, S.A.
EU
Cormeto

Cormeto

Metyrapone

Esteve Pharmaceuticals, S.A.
EU
Cormeto

Cormeto

Metyrapone

Hra Pharma Rare Diseases
EU
Cormeto

Cormeto

Metyrapone

Esteve Pharmaceuticals, S.A.
EU